Varicella Vaccine

1. lyophilized 2. gelatin-free , 3. Free of human serum albumin4. live [Eligibles] Varicella susceptible individuals at the age between 1 year old to 12 years old. Varicella virus vaccine, live attenuated (oka strain) is indicated for:  - The active immunization against varicella of healthy subjects from 12 months to 12 years of age  - The active immunization against varicella of susceptible high-risk patients and their susceptible healthy close contacts in the age group of 12 months to 12 years . [Specifications] 0.5ml of reconstituted vaccine per container. 0.5ml per single human dose containing not less than 3.4Lg PFU Oka virus. [Function and use] The product can induce immunity against varicella-zoster virus in recipients following immunization. It is used to prevent varicella. [Advantages] (1) Have patent for invention of lyophilized protective agent, vaccine and its preparation method; (2) Free of human serum albumin and gelatin with better security; (3) Export to several countries for successive years and top the bestseller list in India; (4) Obtained National Ten Famous-brand Products Honor Certificate in pharmaceutical industry; (5) Gain exclusive approval document: one dose for one to twelve-year-old children as basic immunization, two doses for people no younger than 13 years old and if necessary, people below 12 years old could take one more dose (0.5ml) as booster immunization.